Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial.

CONCLUSIONS EVL-based immunosuppressive therapy with lower Tac exposure could be a safer alternative for maintenance treatment.
PMID: 33479188 [PubMed - in process]

Source: Annals of Transplantation - January 22, 2021 Category: Transplant Surgery Authors: Kim HD, Chang JY, Chung BH, Kim CD, Lee SH, Kim YH, Yang CW Tags: Ann Transplant Source Type: research